akaritx.com (AKTX) Company Sales Volume

akaritx.com - graphic logo of issuer AKTX

Akari Therapeutics relies on a strong staff of biochemists and immunologists. The company's revenue chart demonstrates current dynamics, where the 0.00 mark records this indicator. The strategy is based on creating proteins for the therapy of orphan pathologies, which minimizes risks. Business flexibility is ensured through the complete outsourcing of production and the conduct of all clinical tests by external contractors.

AKTX Akari Therapeutics plc: Revenue and Sales Volume in the range 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Akari Therapeutics PLC (AKTX)

- price and consensus price forecast:
Comprehensive company analysis:Akari Therapeutics - AKTX
Core merchandise of Akari Therapeutics Plc

Akari Therapeutics sales measure the total volume of products sold, reflecting the business's fundamental ability to generate cash flow. Revenue dynamics, which have reached 0.00, confirm financial stability and the market demand for assets. By analyzing the company's current sales figures, an investor can determine the industry cycle phase amid macroeconomic shifts. This is critical for Akari Therapeutics, as geopolitical instability directly impacts drug logistics and international patent protection.

Key competitors

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|Pharvaris - Company Revenue|ABCL - Company Revenue|TRML - Revenue and Sales Volume|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|Company Sales NKTR|UPB: Company Sales Revenue|Company Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Sales Revenue|Revenue and Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Annual Revenue|SEPN - Company Revenue|Company Sales Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Revenue|Rigel Pharmaceuticals Inc (RIGL) - Revenue and Sales Volume|Company Revenue AnaptysBio|Astria Therapeutics - Company Annual Revenue|Revenue and Sales Volume ENGN|Company Total Sales RAPT|Company Revenue Aerovate Therapeutics, Inc. JBIO|Aclaris Therapeutics (ACRS) - Company Total Revenue|KYTX: Company Sales|Company Gross Revenue Tiziana Life Sciences TLSA|CABA: Revenue and Sales Volume|Company Total Revenue Ventyx Biosciences Inc. (VTYX)|Company Sales THTX|Avalo Therapeutics, Inc (AVTX) - Company Gross Revenue|Revenue and Sales Volume ELDN|Company Sales agenusbio.com AGEN|Revenue and Sales Volume CLYM (climbbio.com)|Revenue and Sales Volume Zura Bio Ltd ZURA|ATYR - Company Revenue|Adagene Inc (ADAG) - Company Sales|IMA: Revenue and Sales Volume|Shattuck Therapeutics (STTK) - Revenue and Sales Volume|Company Revenue equilliumbio.com|CNTB: Company Sales Revenue|Revenue and Sales Volume IMUX|ATRA (Atara Bio) - Company Sales Revenue|Company Revenue InflaRx N.V. IFRX|x4pharma.com - Company Revenue|ACET - Company Revenue|Company Sales Revenue CELU (celularity.com)|INMB: Revenue and Sales Volume|Barinthus Biotherapeutics Corp - Company Sales Revenue|Company Sales KZR|Company Sales SAB Biotherapeutics (SABS)|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume